Showing results (11-20 of 142) with videos related to

Sort By:
Pageof 15
Vaccine|May 8, 2012
Lymphocyte-polarized dendritic cells are highly effective in inducing tumor-specific CTLsErik Berk, Ravikumar Muthuswamy, Pawel Kalinski
Expert Review of Vaccines|March 19, 2013
Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapiesPawel Kalinski, Ravikumar Muthuswamy, Julie Urban
Journal for Immunotherapy of Cancer|May 19, 2025
Paclitaxel, interferons and functional reprogramming of tumor-associated macrophages in optimized chemo-immunotherapyPawel Kalinski, Kathleen M Kokolus, Shipra Gandhi
Gene Therapy|April 3, 2025
Is dystrophin immunogenicity a barrier to advancing gene therapy for Duchenne muscular dystrophy?Dariusz C Górecki, Pawel Kalinski, Joanna Pomeroy
Methods in Enzymology|March 4, 2020
Quantitative evaluation of tumor-specific T cells in tumors and lymphoid tissuesKathleen M Kokolus, Nataša Obermajer, Pawel Kalinski
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2024
Dendritic Cell Plasticity, Radiation, and Newton's Third LawPawel Kalinski, Shipra Gandhi, Kathleen M Kokolus
Methods in Molecular Biology (Clifton, N.J.)|November 27, 2009
Generation of stable Th1/CTL-, Th2-, and Th17-inducing human dendritic cellsPawel Kalinski, Eva Wieckowski, Ravikumar Muthuswamy, et al.
Trends in Research|November 12, 2020
Role of tumor microenvironment in the efficacy of BCG therapyOmar M Ibrahim, Ravindra K Pandey, Gurkamal Chatta, et al.
Oncoimmunology|November 15, 2013
IL-18-based combinatorial adjuvants promote the intranodal production of CCL19 by NK cells and dendritic cells of cancer patientsJeffrey L Wong, Ravikumar Muthuswamy, David L Bartlett, et al.
Pageof 15